Company / SG&A per Share
Entrada Therapeutics, Inc. SG&A per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.02
FY2025
5-year range
$0.97 / $1.02
FY2023-FY2025
Trend
+6.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share remained relatively stable over the past 3 years, with values between $0.97 and $1.02.
Based on SEC 10-K filings.
1.02 in FY2025.
Increased from $0.98 to $1.02 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 6.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.03 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.02 | +6.0% |
| FY2024 | $0.97 | -1.0% |
| FY2023 | $0.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026